Relmada Therapeutics, Inc. Appoints Christopher W. James as Senior Director of Clinical Development
Relmada Therapeutics, Inc., a clinical-stage company developing novel therapies for the treatment of chronic pain, announced today that it has appointed Mr. Christopher W. James to the position of Senior Director of Clinical Development.
View full press release